The PI3K-AKT-mTOR signaling cascade is one of the most frequently upregulated pathways in prostate cancer, which potentiates multiple downstream signaling events to mediate a plethora of cellular processes that promote tumor growth and therapeutic resistance to current treatment regimens. This evidence concerns the gene AKT1 and prostate carcinoma.